Results 131 to 140 of about 43,468 (306)
Investigation of the Pathomechanism of Chronic Cough Using an In Vitro Approach
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 247-249, March 2025.
Umesh Singh, Jonathan A. Bernstein
wiley +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza +27 more
wiley +1 more source
Frontiers in NeurologyMigraine is a common neurological disorder with a typical onset in adolescence or early adulthood. Migraine is three times more common in women than men, but the definitive cause underlying the observed disparity is not fully understood.
Lakeisha A. Lewter +4 more
doaj +1 more source
Comparison of CGRP and NO Responses in the Human Peripheral Microcirculation of Migraine and Control Subjects [PDF]
, 2008 M-L Edvinsson, Lars Edvinsson
openalex +1 more source
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study [PDF]
, 2023 Alicia Alpuente +5 more
openalex +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective To evaluate the effect of erenumab treatment beyond monthly migraine days in patients with high‐frequency episodic migraine who did not respond to at least one previous migraine preventive treatment. Background Reduction in monthly migraine days has been the efficacy standard for migraine preventive treatments; however, it does not ...
Gabriel Paiva da Silva Lima +11 more
wiley +1 more source
TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Background The transient receptor potential melastatin 3 (TRPM3) ion channel has been implicated in sensory modulation and pain transmission and may contribute to migraine pathophysiology through calcitonin gene‐related peptide (CGRP) release in the trigeminovascular system. This study aimed to investigate TRPM3 activation and its role in CGRP
Philip V. Reducha +9 more
wiley +1 more source
Receptors mediating CGRP‐induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by hα CGRP8–37 [PDF]
, 1999 F M Wisskirchen +2 more
openalex +1 more source
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients [PDF]
, 2022 Manuela Rizzi +22 more
openalex +1 more source
First successful protocol for desensitization to eptinezumab
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Background Eptinezumab is an anti‐calcitonin gene‐related peptide monoclonal antibody used for migraine prevention. During clinical trials, hypersensitivity to eptinezumab was described without a clear underlying mechanism. To determine if the reaction was immunoglobulin E–mediated, the team of Nice University Hospital (Nice, France) performed
Benoit Gerard +8 more
wiley +1 more source